Corrigendum to "Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer": [ESMO Open 8 (2023) 102039].

Nannini M; Repaci A; Nigro MC; Colapinto A; Vicennati V; Maloberti T; Gruppioni E; Altimari A; Solaroli E; Lodi Rizzini E; Monari F; De Leo A; Damiani S; Pagotto U; Pantaleo MA; de Biase D; Tallini G

doi:10.1016/j.esmoop.2024.103704

← 뒤로

Corrigendum to "Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer": [ESMO Open 8 (2023) 102039].

0/5 보강

ESMO open 📖 저널 OA 100% 2022~2026 2024 Vol.9(11) p. 103704

Nannini M, Repaci A, Nigro MC, Colapinto A, Vicennati V, Maloberti T

📖 무료 전문 🟢 PMC 전문 PMC11670683

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Nannini M, Repaci A, et al. (2024). Corrigendum to "Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer": [ESMO Open 8 (2023) 102039].. ESMO open, 9(11), 103704. https://doi.org/10.1016/j.esmoop.2024.103704

MLA Nannini M, et al.. "Corrigendum to "Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer": [ESMO Open 8 (2023) 102039].." ESMO open, vol. 9, no. 11, 2024, pp. 103704.

PMID 39617534 ↗

DOI 10.1016/j.esmoop.2024.103704

같은 제1저자의 인용 많은 논문 (3)

Plasma over tissue? Liquid biopsy in the management of gastrointestinal stromal tumors (GISTs).
Critical reviews in oncology/hematology 2026
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer.
ESMO open 2023
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma.
Frontiers in oncology 2022